PL3299364T3 - Sposób syntezy nebiwololu i jego związek pośredni - Google Patents

Sposób syntezy nebiwololu i jego związek pośredni

Info

Publication number
PL3299364T3
PL3299364T3 PL15892188T PL15892188T PL3299364T3 PL 3299364 T3 PL3299364 T3 PL 3299364T3 PL 15892188 T PL15892188 T PL 15892188T PL 15892188 T PL15892188 T PL 15892188T PL 3299364 T3 PL3299364 T3 PL 3299364T3
Authority
PL
Poland
Prior art keywords
nebiwolol
synthesis
indirect relationship
indirect
relationship
Prior art date
Application number
PL15892188T
Other languages
English (en)
Inventor
Zhiguo Zheng
Original Assignee
Zhejiang Ausun Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Ausun Pharmaceutical Co., Ltd. filed Critical Zhejiang Ausun Pharmaceutical Co., Ltd.
Publication of PL3299364T3 publication Critical patent/PL3299364T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76Benzo[c]pyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/20Preparation of ethers by reactions not forming ether-oxygen bonds by hydrogenation of carbon-to-carbon double or triple bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/22Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of halogens; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/30Preparation of ethers by reactions not forming ether-oxygen bonds by increasing the number of carbon atoms, e.g. by oligomerisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/257Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
    • C07C43/295Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/02Synthesis of the oxirane ring
    • C07D301/03Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
    • C07D301/14Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with organic peracids, or salts, anhydrides or esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/02Synthesis of the oxirane ring
    • C07D301/03Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
    • C07D301/19Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with organic hydroperoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/36Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Epoxy Compounds (AREA)
  • Pyrane Compounds (AREA)
PL15892188T 2015-05-19 2015-05-19 Sposób syntezy nebiwololu i jego związek pośredni PL3299364T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2015/079329 WO2016183809A1 (zh) 2015-05-19 2015-05-19 奈必洛尔的合成方法及其中间体化合物
EP15892188.2A EP3299364B1 (en) 2015-05-19 2015-05-19 Nebivolol synthesis method and intermediate compound thereof

Publications (1)

Publication Number Publication Date
PL3299364T3 true PL3299364T3 (pl) 2022-02-07

Family

ID=57319165

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15892188T PL3299364T3 (pl) 2015-05-19 2015-05-19 Sposób syntezy nebiwololu i jego związek pośredni

Country Status (8)

Country Link
US (3) US10526304B2 (pl)
EP (2) EP3299364B1 (pl)
JP (1) JP6847095B2 (pl)
KR (2) KR102756069B1 (pl)
CN (2) CN107531662B (pl)
ES (1) ES2901966T3 (pl)
PL (1) PL3299364T3 (pl)
WO (1) WO2016183809A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3299364B1 (en) 2015-05-19 2021-10-20 Zhejiang Ausun Pharmaceutical Co., Ltd. Nebivolol synthesis method and intermediate compound thereof
CN117567422A (zh) * 2023-11-24 2024-02-20 江苏威奇达药业有限公司 一种连续流反应合成盐酸奈必洛尔的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337429C (en) 1983-12-05 1995-10-24 Guy Rosalia Eugene Van Lommen Derivatives of 2,2'-iminobisethanol
US6545040B1 (en) 1988-03-23 2003-04-08 Janssen Pharmaceutica N.V. Method of lowering the blood pressure
CA1337432C (en) 1988-03-23 1995-10-24 Raymond M. Xhonneux Method of lowering the blood pressure
CN100387586C (zh) 2005-03-18 2008-05-14 中国科学院理化技术研究所 手性2-胺基-1-(6-氟-3,4-二氢苯并吡喃基)乙醇的合成方法
AT502220A1 (de) 2005-07-19 2007-02-15 Pharmacon Forschung & Beratung Verfahren zur herstellung von nebivolol
CN1978442A (zh) 2005-12-02 2007-06-13 中国科学院理化技术研究所 (r,r,r,s)2,2'-[亚氨基二(亚甲基)]双-(6-氟-3,4-二氢-2h-1-苯骈吡喃-2-甲醇)奈吡咯尔盐酸盐的合成方法
CA2667919C (en) * 2006-11-27 2014-10-28 Zach System S.P.A. Process for preparing nebivolol
PL2102196T3 (pl) 2006-11-27 2012-12-31 Zach System Spa Sposób wytwarzania nebiwololu
CN101463024B (zh) * 2007-12-21 2011-06-08 上海现代制药股份有限公司 一种制备rrrs和sssr型的奈必洛尔中间体混合物的方法
IT1397962B1 (it) 2010-02-11 2013-02-04 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
US20110250454A1 (en) 2010-04-09 2011-10-13 Pranab Haldar Preparation of nebivolol
WO2011132140A2 (en) * 2010-04-20 2011-10-27 Cadila Pharmaceuticals Limited Process for the conversion of (2r)-6-fluoro-2-[(2s)-oxiran-2-yl]-3,4-dihydro-2h-chromene to (2r)-6-fluoro-2-[(2r)-oxiran-2-yl]-3,4-dihydro-2h-chromene
CN102344431B (zh) 2010-08-05 2014-03-26 成都康弘药业集团股份有限公司 一种制备奈必洛尔盐酸盐的方法
GB201101959D0 (en) 2011-02-04 2011-03-23 Univ Nottingham Novel ether linked compoundsand improved treatments for cardiac and cardiovascular disease
ITRM20110418A1 (it) 2011-08-02 2013-02-03 Menarini Int Operations Lu Sa Processo per la preparazione di epossidi quali intermedi per la sintesi del nebivololo.
CN102816141A (zh) 2012-09-10 2012-12-12 济南爱思医药科技有限公司 一种制备奈必洛尔消旋体盐酸盐的方法
CN104650022B (zh) 2013-11-20 2018-09-25 浙江奥翔药业股份有限公司 奈必洛尔的合成方法及其中间体化合物
CN103833717B (zh) 2014-03-28 2016-03-30 北京师范大学 一种奈必洛尔盐酸盐的合成方法
DE102014107132A1 (de) 2014-05-20 2015-11-26 Corden Pharma International Gmbh Verfahren zur Herstellung von Epoxiden die in der Herstellung von Nebivolol und dessen Derivaten einsetzbar sind
EP3299364B1 (en) 2015-05-19 2021-10-20 Zhejiang Ausun Pharmaceutical Co., Ltd. Nebivolol synthesis method and intermediate compound thereof

Also Published As

Publication number Publication date
US20180141926A1 (en) 2018-05-24
EP3974419A3 (en) 2022-07-27
KR102756069B1 (ko) 2025-01-22
US20220056003A1 (en) 2022-02-24
CN107531662B (zh) 2021-08-06
KR102529680B1 (ko) 2023-05-09
US12466802B2 (en) 2025-11-11
US10526304B2 (en) 2020-01-07
KR20230068441A (ko) 2023-05-17
KR20180004810A (ko) 2018-01-12
US20200102282A1 (en) 2020-04-02
CN107531662A (zh) 2018-01-02
ES2901966T3 (es) 2022-03-24
US11142512B2 (en) 2021-10-12
WO2016183809A1 (zh) 2016-11-24
EP3974419A2 (en) 2022-03-30
JP2018522060A (ja) 2018-08-09
EP3299364B1 (en) 2021-10-20
EP3299364A4 (en) 2019-03-20
CN113563295A (zh) 2021-10-29
EP3299364A1 (en) 2018-03-28
JP6847095B2 (ja) 2021-03-24

Similar Documents

Publication Publication Date Title
PL3183260T3 (pl) Modyfikowane oligonukleotydy i sposoby ich syntezy
DK3317284T3 (da) Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse
PL3167096T3 (pl) Dwuetapowy sposób nanoszenia
HUE052373T2 (hu) Szubsztituált krománok és alkalmazási eljárások
PL3353210T3 (pl) Przeciwciała anty-TIGIT i sposoby stosowania
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
PL3325443T3 (pl) Sposób otrzymywania pridopidyny
DK3218005T3 (da) Glycan-interagerende forbindelser og anvendelsesfremgangsmåder
DK3089971T3 (da) Forbindelser og fremgangsmåder til anvendelse
EP3386505A4 (en) AZA-BENZIMIDAZOLINHIBITORS OF PAD4
IL272851A (en) Methods of using dipivefrin
DK3283210T3 (da) Fremgangsmåde
DK3288379T3 (da) Peptidsammensætninger og anvendelsesmåder
PL3393468T3 (pl) Metody leczenia niedoboru odporności
DK3389669T3 (da) Triterpensaponinvarianter, syntesefremgangsmåder og anvendelse deraf
IL313083A (en) Terlipressin compositions and their methods of use
DK3137873T3 (da) Viscometer and methods of use thereof
IL254502B (en) Solid forms of menaquinols
EP3277701A4 (en) SYNTHESIS OF DESOSAMINES
PL3309149T3 (pl) Kryształ 6-bromo-3-hydroksy-2-pirazynokarboksamidu i sposób jego wytwarzania
LT3253772T (lt) Diosmino ruošimo būdas
PL3180295T3 (pl) Sposób szybkiej humifikacji i biostabilizacji
PL3299364T3 (pl) Sposób syntezy nebiwololu i jego związek pośredni
DK3285588T3 (da) Fremgangsmåde
PL3350308T3 (pl) Zastosowanie włókna liocelowego